▶︎ CYTOVALE
San Francisco, US · Delaware corporation · 9 known investors
Cytovale develops microfluidic deformability cytometry technology for immune response diagnostics, with a focus on early detection and diagnosis in hospital settings. The company serves healthcare systems and clinicians with diagnostic instruments and solutions.
Founders & leadership
Investors · 9
Alumni VenturesManchester · $100K – $10M
Basecamp FundManchester · $100K – $10M
Breakout Labs
Breakout VenturesSan Francisco · $500K – $6M
EMV CapitalLondon
IT-Farm CorporationTokyovia Julien Nguyen · inferred
Norwest Venture PartnersMenlo Park · $10M – $30M
Pathway BioventuresChicago
Dolby Family VenturesreportedSan Francisco
Reported raises · per SEC filings
Form D private placements▶$16.4MraisedJan 2022 · 23 investors · BiotechnologyRule 506(b)
▶$16.4MraisedJan 2022 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dino DiCarloDirector, Promoter
- William BlackledgeExecutive Officer
- Lindy FishburneDirector
- Jack FuchsDirector, Promoter
- Ajay ShahExecutive Officer, Director, Promoter
- Henry TseExecutive Officer
- Jordanna Polis SchutzDirector
- Offering amount
- $20M
- Amount sold
- $16.4M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.4MraisedOct 2019 · 15 investors · BiotechnologyRule 506(b)
▶$7.4MraisedOct 2019 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lindy FishburneDirector
- Jack FuchsDirector, Promoter
- Dino DiCarloDirector, Promoter
- Ajay ShahExecutive Officer, Director, Promoter
- Jordanna Polis SchutzDirector
- Offering amount
- $8.4M
- Amount sold
- $7.4M
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.2MraisedDec 2017 · 7 investors · OtherRule 506(b)
▶$7.2MraisedDec 2017 · 7 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Lindy FishburneDirector
- Ajay ShahExecutive Officer, Director, Promoter
- Dino DiCarloDirector, Promoter
- Jack FuchsDirector, Promoter
- Offering amount
- $11M
- Amount sold
- $7.2M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Forward Financing $525 Million: VFN + ABS Deal Explainedfunderintel.com · 2026